Sensus Healthcare, Inc.
NASDAQ:SRTS
6.07 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 24.405 | 44.532 | 27.042 | 9.577 | 27.263 | 26.427 | 20.588 | 14.811 | 10.273 | 5.81 | 10.479 |
| Cost of Revenue
| 10.345 | 14.904 | 10.054 | 4.328 | 9.706 | 9.516 | 6.788 | 4.965 | 3.699 | 2.055 | 3.6 |
| Gross Profit
| 14.06 | 29.628 | 16.988 | 5.249 | 17.557 | 16.911 | 13.8 | 9.846 | 6.574 | 3.755 | 6.879 |
| Gross Profit Ratio
| 0.576 | 0.665 | 0.628 | 0.548 | 0.644 | 0.64 | 0.67 | 0.665 | 0.64 | 0.646 | 0.656 |
| Reseach & Development Expenses
| 3.678 | 3.46 | 3.436 | 4.157 | 6.418 | 6.26 | 5.49 | 1.824 | 1.467 | 1.577 | 1.333 |
| General & Administrative Expenses
| 5.156 | 5.008 | 4.594 | 3.989 | 4.005 | 4.124 | 3.722 | 3.469 | 1.586 | 1.651 | 1.453 |
| Selling & Marketing Expenses
| 5.608 | 6.329 | 4.838 | 5.336 | 9.103 | 8.532 | 8.305 | 4.915 | 3.743 | 4.208 | 3.965 |
| SG&A
| 10.764 | 11.337 | 9.432 | 9.326 | 13.108 | 12.656 | 12.027 | 8.385 | 5.329 | 5.859 | 5.419 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 14.442 | 14.797 | 12.868 | 13.483 | 19.525 | 18.916 | 17.517 | 10.209 | 6.796 | 7.436 | 6.752 |
| Operating Income
| -0.382 | 14.831 | 4.12 | -8.234 | -1.968 | -2.005 | -3.717 | -0.363 | -0.221 | -3.68 | 0.127 |
| Operating Income Ratio
| -0.016 | 0.333 | 0.152 | -0.86 | -0.072 | -0.076 | -0.181 | -0.025 | -0.022 | -0.633 | 0.012 |
| Total Other Income Expenses Net
| 1.034 | 13.159 | -0.001 | 1.398 | 0.268 | -0.017 | 0.007 | 0.017 | -0.016 | -0.019 | -0.019 |
| Income Before Tax
| 0.652 | 27.99 | 4.119 | -6.836 | -1.7 | -2.023 | -3.711 | -0.346 | -0.237 | -3.699 | 0.108 |
| Income Before Tax Ratio
| 0.027 | 0.629 | 0.152 | -0.714 | -0.062 | -0.077 | -0.18 | -0.023 | -0.023 | -0.637 | 0.01 |
| Income Tax Expense
| 0.167 | 3.746 | -0.613 | -2.12 | -0.546 | 0.139 | -0.312 | -0.299 | 0.002 | 0.001 | 0.001 |
| Net Income
| 0.485 | 24.244 | 4.119 | -4.715 | -1.154 | -2.023 | -3.711 | -0.346 | -0.237 | -3.699 | 0.108 |
| Net Income Ratio
| 0.02 | 0.544 | 0.152 | -0.492 | -0.042 | -0.077 | -0.18 | -0.023 | -0.023 | -0.637 | 0.01 |
| EPS
| 0.03 | 1.47 | 0.25 | -0.29 | -0.071 | -0.14 | -0.28 | -0.029 | -0.022 | -0.37 | -0.041 |
| EPS Diluted
| 0.03 | 1.46 | 0.25 | -0.29 | -0.071 | -0.14 | -0.28 | -0.029 | -0.022 | -0.37 | -0.041 |
| EBITDA
| 0.03 | 15.213 | 4.12 | -9.58 | -1.7 | -1.866 | -3.642 | -0.325 | 0.096 | -3.407 | 0.394 |
| EBITDA Ratio
| 0.001 | 0.342 | 0.152 | -1 | -0.062 | -0.071 | -0.177 | -0.022 | 0.009 | -0.586 | 0.038 |